# Analyte Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/analyte-health

- Industry: Healthcare IT
- Headquarters: Houston, US
- Website: www.analytehealth.com
- Total disclosed funding: $22M
- Latest round: Series C (Jul 25, 2012)
- Investors on record: 5

## About

Based in the US, Analyte Health provides accessible online healthcare services through a user-friendly platform, ensuring efficient and private consultations with healthcare professionals.Founded in 2010 in Houston, US, Analyte Health operates online to enhance patient access to healthcare services. The company has engaged in five funding deals, with the latest round raising USD 6.50 mn. In August 2025, Analyte Health was acquired by Brightstar Capital Partners, previously backed by several venture firms including Apex Venture Partners. The founder, Fiyyaz Pirani, is instrumental in steering the company's direction.Analyte Health specializes in delivering accessible and affordable online healthcare services that integrate technology with patient-centric care. Their core offerings include a user-friendly online platform for fast and private consultations with trained health counselors and physicians. Catering to diverse clientele, their 24/7 services address healthcare needs in urban and suburban areas, facilitating timely medical advice and treatment outside traditional settings.Analyte Health's revenue model is based on direct-to-consumer transactions, allowing patients to access various health services promptly. The structure includes service fees for consultations and potential subscription plans for ongoing care. It offers tiered pricing options based on service complexity, ensuring affordable access to care while positioning itself to meet the growing demand for digital health services.In August 2025, Analyte Health was acquired by Brightstar Capital Partners, with the acquisition aimed at driving long-term growth. The company plans to develop and launch new products while expanding into additional geographic markets, although specific details on the products or target markets have not been disclosed. The funding from the acquisition will support these initiatives, bolstering the company's strategic growth.

## Funding rounds

- Series C, Jul 25, 2012, $22M — Apex Venture Partners, Mohr Davidow Ventures, Pritzker Group Venture Capital
- Series A, May 1, 2011 — Apex Venture Partners, Draper Fisher Jurvetson, Pritzker Group Venture Capital, DFJ Portage Venture Partners

## Investors

- Apex Venture Partners (https://capitalatlas.ai/funds/apex-venture-partners) — Series A, Series C
- Draper Fisher Jurvetson (https://capitalatlas.ai/funds/draper-fisher-jurvetson) — Series A
- Pritzker Group Venture Capital (https://capitalatlas.ai/funds/pritzker-group-venture-capital) — Series A, Series C
- DFJ Portage Venture Partners (https://capitalatlas.ai/funds/dfj-portage-venture-partners) — Series A
- Mohr Davidow Ventures (https://capitalatlas.ai/funds/mohr-davidow-ventures) — Series C